Featured Research

from universities, journals, and other organizations

Injection lowers cholesterol in preliminary human trial

Date:
November 30, 2011
Source:
American Heart Association
Summary:
Patients unable to control their cholesterol levels with medications may someday be able to lower their "bad" cholesterol with a shot, according to new research.

Patients unable to control their cholesterol levels with medications may someday be able to lower their "bad" cholesterol with a shot, according to research presented at the American Heart Association's Scientific Sessions 2011.

In its first preliminary human tests, the medicine in the new shot lowered low density lipoprotein, or "bad" cholesterol, in healthy volunteers who received the highest dose an average 64 percent more than those who received an inactive placebo injection.

The injected material -- targeting a recently-identified cholesterol regulator -- is a monoclonal antibody that's a laboratory-made human protein. Monoclonal antibodies are already used to treat certain cancers and other medical conditions.

In the study, scientists created the monoclonal antibody AMG145 to disable the cholesterol regulator PCSK9, which interferes with the liver's ability to remove bad cholesterol from the blood. Therefore, turning it off improves cholesterol levels.

"PCSK9 is the first target in lipid metabolism to be inhibited using a monoclonal antibody, and it appears to be a promising way to lower bad cholesterol," said Clapton Dias, Ph.D., lead researcher and medical sciences director of clinical pharmacology and early development at Amgen, Inc., in Thousand Oaks, Ca.

The study involved 54 men and two women, 18 to 45 years old, who were healthy and not taking other medications. Participants received a single injection that contained one of five doses of AMG145 or a placebo. Sixteen received the injections intravenously and the others got simple injections that delivered the drug just underneath the skin.

After the injections, bad cholesterol was measured frequently for 85-113 days, along with other laboratory measures related to heart disease.

With increasing doses of AMG145, blood tests revealed:

  • Less of the active form of PCSK9;
  • Lower levels of bad cholesterol, total cholesterol and apo-B (the primary protein component of bad cholesterol);
  • No effect on triglycerides, high density lipoprotein ("good" cholesterol) or a protein associated with good cholesterol -- all lipid measures were not influenced by the PCSK9 regulator.

"The more PCSK9 was lowered, the more bad cholesterol levels went down," Dias said. "With higher doses, bad cholesterol stayed lower for a longer period."

The injections were tolerated well, with volunteers receiving AMG145 experiencing no more side effects than those receiving the placebo.

The study included a small number of participants, and they were healthy. So the company is conducting a similar study that gives multip

ple doses of AMG145 to adults who take statin medication to control their cholesterol.

If AMG145 proves safe and effective in further clinical trials, it could help people unable to control their cholesterol with current medications that work in different ways.

Co-authors are: Adam Shaywitz, M.D., Ph.D.; Brian Smith, Ph.D.; Maurice Emery, Pharm.D., Ph.D.; Bing Gao, M.S.; John Gibbs, Ph.D.; Bill Wishner, M.D.; Dina Stolman, M.D.; Caroline Crispino, Ph.D.; Blaire Cooke, Pharm. D.; Alex Colbert, Ph.D.; Marc Retter, M.D.; Ren Xu, Ph.D. and Mark Matson, M.D.

Amgen, Inc. funded the study.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Injection lowers cholesterol in preliminary human trial." ScienceDaily. ScienceDaily, 30 November 2011. <www.sciencedaily.com/releases/2011/11/111114093625.htm>.
American Heart Association. (2011, November 30). Injection lowers cholesterol in preliminary human trial. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2011/11/111114093625.htm
American Heart Association. "Injection lowers cholesterol in preliminary human trial." ScienceDaily. www.sciencedaily.com/releases/2011/11/111114093625.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins